Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
EXmoor Pharma and Royal Free London launch strategic collaboration to strengthen UK cell and gene therapy manufacturing pathway
Thursday, November 27, 2025EXmoor Pharma the integrated cell and gene therapy CDMO with embedded consultancy expertise and Royal Free London NHS Foundation Trust through its Cell and Vector Innovation Centre CVIC
Otsuka Pharmaceutical Submits New Drug Application to U.S. FDA for Centanafadine for the Treatment of ADHD in Children, Adolescents, and Adults
Wednesday, November 26, 2025Otsuka Pharmaceutical Co Ltd Otsuka and Otsuka Pharmaceutical Development Commercialization Inc announce the filing of a New Drug Application NDA with the US Food and Drug Administration FDA for centanafadine
Mettler-Toledo Launches X3 Series to Transform Bulk Flow Inspection with Advanced Detection, Hygienic Design and Precision Rejects
Tuesday, November 25, 2025MettlerToledo Product Inspection has unveiled the new X Series of bulk flow xray inspection systems designed to deliver classleading physical contamination detection precision waste reduction and simplified operation
U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Friday, November 21, 2025Bayer announced today that the US Food and Drug Administration FDA has approved HYRNUO sevabertinib an oral reversible tyrosine kinase inhibitor TKI for the treatment of adult patients with locally advanced or metastatic nonsquamous nonsmall cell lun...
Thermo Fisher Scientific’s Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer
Friday, November 21, 2025Thermo Fisher Scientific the world leader in serving science has received approval from the US Food and Drug Administration FDA for its Ion Torrent Oncomine Dx Target Test as a companion diagnostic CDx to identify patients who may be eligible for tre...
OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors
Tuesday, November 18, 2025OmniAb Incand ArrowMark Partners ArrowMark today announced the signing of a license and services agreement for novel OmniAbderived antibody discovery programs with Mabtrx Biosciences
Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD
Tuesday, November 18, 2025Silo Pharma Inc a diversified developmentalstage biopharmaceutical and cryptocurrency treasury company today announced that it has selected Allucent a global fullservice clinical research organization CRO to support the Companys
ITM Announces FDA Acceptance of New Drug Application (NDA) and PDUFA Date for n.c.a. 177Lu-edotreotide (ITM-11) in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Friday, November 14, 2025ITM Isotope Technologies Munich SE ITM a leading radiopharmaceutical biotech company today announced that the US Food and Drug Administration FDA completed its filing review and accepted the companys New Drug Application
Sarah Cannon Research Institute and Bristol Myers Squibb Expand Strategic Collaboration to Accelerate Patient Enrollment and Broaden Access to Innovative Cancer Research
Thursday, November 13, 2025Sarah Cannon Research Institute SCRI one of the worlds leading oncology research organizations conducting communitybased clinical trials and Bristol Myers Squibb NYSE BMY a leading biopharmaceutical company
Integrated DNA Technologies and Beckman Coulter Life Sciences Partner to Advance Cancer Research Through Automated NGS Workflows
Thursday, November 13, 2025Danaher companies Integrated DNA Technologies IDT a global leader in genomics and Beckman Coulter Life Sciences a global leader in laboratory automation and innovation are forming a strategic partnership to automate IDTs
